The efficacy of anti-TNF therapies, despite their success in other autoimmune conditions, remains equivocal in the context of SS, potentially attributed to the complex and multifaceted role of TNF in the disorder’s pathogenesis (Azuma et al., 1997). The gene discussed is TNF; the disease is synovial sarcoma.